Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 13580
Country/Region: Zambia
Year: 2016
Main Partner: Centre for Infectious Diseases Research in Zambia
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $19,032,193 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,800,000
Care: TB/HIV (HVTB) $2,000,000
Care: Pediatric Care and Support (PDCS) $400,000
Strategic Information (HVSI) $450,000
Health Systems Strengthening (OHSS) $100,000
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $1,075,697
Testing: HIV Testing and Counseling (HVCT) $400,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $2,500,000
Treatment: Adult Treatment (HTXS) $9,406,496
Treatment: Pediatric Treatment (PDTX) $900,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: <1 2017 2,338
HTS_TST Age/sex: 1-9 2017 6,038
HTS_TST Age/sex: 10-14 Female 2017 1,581
HTS_TST Age/sex: 10-14 Male 2017 1,806
HTS_TST Age/sex: 15-19 Female 2017 9,113
HTS_TST Age/sex: 15-19 Male 2017 7,942
HTS_TST Age/sex: 20-24 Female 2017 17,229
HTS_TST Age/sex: 20-24 Male 2017 13,526
HTS_TST Age/sex: 25-49 Female 2017 28,472
HTS_TST Age/sex: 25-49 Male 2017 24,857
HTS_TST Age/sex: 50+ Female 2017 2,823
HTS_TST Age/sex: 50+ Male 2017 2,909
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 5,755
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 6,012
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 57,641
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 49,238
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 118,646
HTS_TST Service Delivery Point (Facility): Outpatient 2017 24
HTS_TST Service Delivery Point (Facility): VCT 2017 118,622
HTS_TST Sum of Age/Sex disaggregates 2017 110,258
HTS_TST Sum of Aggregated Age/Sex <15 2017 11,767
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 106,879
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 118,646
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 239
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 424
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 667
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 342
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 1,768
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 1,197
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 3,002
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 3,003
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 225
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 277
HTS_TST_POS Test Result by Age: Positive: <1 2017 130
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 415
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 487
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 719
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 5,673
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 4,811
PMTCT_ART Already on ART at beginning of current pregnancy 2017 7,334
PMTCT_ART New on ART 2017 9,411
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 140,878
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 11,387
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 12,808
PMTCT_EID Sum of Infant Age disaggregates 2017 24,195
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 25,708
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 41,530
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 73,640
PMTCT_STAT By: Known positives at entry 2017 6,755
PMTCT_STAT By: Number of new positives identified 2017 7,369
PMTCT_STAT Number of new ANC and L&D clients 2017 140,876
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 140,878
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 15-19 2017 928
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 2,128
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 3,693
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 15-19 2017 1,019
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 2,320
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 4,031
PMTCT_STAT Sum of Positives Status disaggregates 2017 14,124
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 35
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 25,673
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 41,530
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 73,589
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 50+ 2017 51
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 84
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1,780
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 126
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2,504
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 4,494
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 4,494
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 49,519
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 70,300
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 2,659
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 3,785
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 126,263
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 189
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 4,148
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 251
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 5,519
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 10,107
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 10,107
TX_CURR Age/Sex: <1 2017 1,864
TX_CURR Age/Sex: <1-9 2017 12,697
TX_CURR Age/Sex: 10-14 Female 2017 3,169
TX_CURR Age/Sex: 10-14 Male 2017 2,935
TX_CURR Age/Sex: 15-19 Female 2017 4,412
TX_CURR Age/Sex: 15-19 Male 2017 1,276
TX_CURR Age/Sex: 20-24 Female 2017 15,572
TX_CURR Age/Sex: 20-24 Male 2017 3,954
TX_CURR Age/Sex: 25-49 Female 2017 93,536
TX_CURR Age/Sex: 25-49 Male 2017 56,325
TX_CURR Age/Sex: 50+ Female 2017 8,107
TX_CURR Age/Sex: 50+ Male 2017 5,768
TX_CURR Aggregated Age/Sex: <15 Female 2017 10,870
TX_CURR Aggregated Age/Sex: <15 Male 2017 9,766
TX_CURR Aggregated Age/Sex: 15+ Female 2017 121,385
TX_CURR Aggregated Age/Sex: 15+ Male 2017 67,323
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 209,615
TX_CURR Sum of age/sex disaggregates 2017 5,688
TX_CURR Sum of Aggregated Age/Sex <15 2017 20,636
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 188,708
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 209,344
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 2,326
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 2,156
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 25,628
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 14,996
TX_NEW By Age/Sex: <1 2017 379
TX_NEW By Age/Sex: 1-9 2017 2,726
TX_NEW By Age/Sex: 10-14 Female 2017 677
TX_NEW By Age/Sex: 10-14 Male 2017 700
TX_NEW By Age/Sex: 15-19 Female 2017 949
TX_NEW By Age/Sex: 15-19 Male 2017 262
TX_NEW By Age/Sex: 20-24 Female 2017 3,375
TX_NEW By Age/Sex: 20-24 Male 2017 844
TX_NEW By Age/Sex: 25-49 Female 2017 19,772
TX_NEW By Age/Sex: 25-49 Male 2017 12,428
TX_NEW By Age/Sex: 50+ Female 2017 1,751
TX_NEW By Age/Sex: 50+ Male 2017 1,243
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 45,106
TX_NEW Sum of Age/Sex disaggregates 2017 42,001
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 45,106
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 50,216
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 50,216
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 569
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 950
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 20,166
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 28,531
TX_PVLS Numerator: Indication: Routine 2017 37,642
TX_PVLS Numerator: Indication: Targeted 2017 12,574
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 569
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 950
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 20,166
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 28,531
TX_PVLS_den Denominator: Indication: Routine 2017 37,642
TX_PVLS_den Denominator: Indication: Targeted 2017 12,574
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 234
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,800
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 440
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 522
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 625
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 169
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,250
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 558
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 13,445
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 8,184
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,164
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 821
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,524
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,472
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 17,484
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 9,732
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 30,212
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 30,212
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 234
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,800
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 440
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 522
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 625
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 169
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,250
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 558
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 13,445
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 8,184
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,164
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 821
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,524
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,472
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 17,484
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 9,732
VMMC_CIRC By Age: 10-14 2017 4,450
VMMC_CIRC By Age: 15-19 2017 7,076
VMMC_CIRC By Age: 20-24 2017 3,969
VMMC_CIRC By Age: 25-29 2017 2,633
VMMC_CIRC By Age: 30-49 2017 1,969
VMMC_CIRC By Age: 50+ 2017 56
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 20,153
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 20,153
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 20,153
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 15,551